SCHEMBL138593

SCHEMBL138593

O=C1NC=CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL15912968 0.97
Hydrogen Sulfide SCHEMBL28247541 0.97
Hydrochloric Acid SCHEMBL8321559 0.97
SCHEMBL15388886 0.86
SCHEMBL9954714 0.82
SCHEMBL18324454 0.81
SCHEMBL28904926 0.78
SCHEMBL11318485 0.78
SCHEMBL586833 0.74
SCHEMBL293787 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2882 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130899-A1 METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2026-05-14 US claimed
EP-3843845-B1 INHIBITION OF PROTEIN KINASES TO TREAT FRIEDREICH ATAXIA UNIV MASSACHUSETTS (US) 2026-03-11 EP claimed
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2026-02-19 US claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
WO-2025203024-A1 PROCESS FOR PREPARING 5-FLUORO-4-IMINO-3-METHYL-1-(TOLUENE-4-SULFONYL)-3,4-DIHYDRO-1H-PYRIMIDIN-2-ONE ADAMA MAKHTESHIM LTD. (IL) 2025-10-02 WO claimed
EP-4622621-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL Symrise AG (DE) 2025-10-01 EP claimed
EP-4551569-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-05-14 EP claimed
CN-113825747-B Fluorolactones and process for producing the same 大金工业株式会社 2025-04-25 CN claimed
US-12281308-B2 Inhibition of protein kinases to treat Friedreich ataxia UNIVERSITY OF MASSACHUSETTS (US) 2025-04-22 US claimed
WO-2001053477-A1 METHODS AND COMPOSITIONS FOR CONTROL OF BONE FORMATION VIA MODULATION OF NEUROPEPTIDE Y ACTIVITY BAYLOR COLLEGE OF MEDICINE (US) 2001-07-26 WO claimed
WO-2000051639-A2 TREATMENT OF NEOPLASTIC DISEASES BY RADIATION HALOGENETICS, INC. (US) 2000-09-08 WO claimed
EP-1003734-A2 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST Merck & Co., Inc. (US) 2000-05-31 EP claimed
WO-1999007695-A2 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST MERCK & CO., INC. (US) 1999-02-18 WO claimed
WO-1990006118-A1 THERAPEUTIC USE OF DIHYDROPYRIMIDONES AND BENZAZEPINE AND BENZOTHIAZEPINE DERIVATIVES IN RETINAL OR OPTIC NERVE DYSFUNCTION HOUSTON BIOTECHNOLOGY INCORPORATED (US) 1990-06-14 WO claimed
US-4695633-A Chromogenic 4,4-diaryl-dihydroquinazolones, their preparation and their use BAYER AKTIENGESELLSCHAFT (DE) 1987-09-22 US claimed
US-4514210-A Herbicidally active methyl-substituted tetrahydro-2-pyrimidinone derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-04-30 US claimed
EP-0058868-B1 DERIVATIVES OF TETRAHYDROPYRIMIDINON, PROCESS FOR THEIR PREPARATION AND HERBICIDES CONTAINING THOSE DERIVATIVES AS ACTIVE PRODUCTS NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1984-04-11 EP claimed
US-4402731-A Herbicidally active novel substituted tetrahydropyrimidinones NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1983-09-06 US claimed
US-4041222-A 2-OXOTETRAHYDROPYRIMIDINES BASF AKTIENGESELLSCHAFT (DT) 1977-08-09 US claimed